Endocrine Role of the renin-angiotensin system in human adipose tissue and muscle: Effect of β-adrenergic stimulation

Hypertension

Volumn 49, Issue 3, 2007, Pages 542-547

  Goossens, Gijs H ^a,c   Jocken, Johan W E ^a   Blaak, Ellen E ^a   Schiffers, Paul M ^b   Saris, Wim H M ^a   Van Baak, Marleen A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c NONE   (Netherlands)

Author keywords

adrenergic receptors; Angiotensin; Obesity; Renin; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; RENIN;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BETA ADRENERGIC STIMULATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOCRINE FUNCTION; HUMAN; HUMAN TISSUE; LEAN BODY WEIGHT; MALE; MUSCLE; OBESITY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; SKELETAL MUSCLE; TISSUE BLOOD FLOW;

ABDOMEN; ADIPOSE TISSUE; ANGIOTENSIN II; ANGIOTENSINOGEN; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; RECEPTORS, ADRENERGIC, BETA; REGIONAL BLOOD FLOW; RENIN-ANGIOTENSIN SYSTEM;

EID: 33847054376     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000256091.55393.92     Document Type: Article

References (33)

1. Sharma AM. The obese patient with diabetes mellitus: from research targets to treatment options. Am J Med. 2006;119:S17-S23.
2. Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol. 2006;98:121-128.
3. Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens. 2005;23:463-473.
4. Goossens GH, Blaak EE, van Baak MA. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev. 2003;4:43-55.
5. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension. 2005;45:356-362.
6. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995;95:948-953.
7. Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D, Ward R, Forrester T. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens. 1997;11:107-111.
8. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens. 1997;10:629-633.
9. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 2001;15:2727-2729.
10. Hsueh WA, Goldstone R, Carlson EJ, Horton R. Evidence that the beta-adrenergic system and prostaglandins stimulate renin release through different mechanisms. J Clin Endocrinol Metab. 1985;61:399-403.
11. Taddei S, Virdis A, Mattei P, Favilla S, Salvetti A. Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. Hypertension. 1995;25:595-601.
12. Taddei S, Salvetti A. Vascular tissue renin-angiotensin system in hypertensive humans. J Hypertens. 1992;10(suppl):S165-S172.
13. Goossens GH, Blaak EE, Saris WH, Van Baak MA. Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects. J Clin Endocrinol Metab. 2004;89:2690-2696.
14. Abumrad NN, Rabin D, Diamond MP, Lacy WW. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism. 1981;30:936-940.
15. Frayn KN, Coppack SW, Humphreys SM, Whyte PL. Metabolic characteristics of human adipose tissue in vivo. Clin Sci (Colch). 1989;76:509-516.
16. Coppack SW, Frayn KN, Humphreys SM, Dhar H, Hockaday TD. Effects of insulin on human adipose tissue metabolism in vivo. Clin Sci (Colch). 1989;77:663-670.
17. Coppack SW, Frayn KN, Humphreys SM, Whyte PL, Hockaday TD. Arteriovenous differences across human adipose and forearm tissues after overnight fast. Metabolism. 1990;39:384-390.
18. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. Am J Physiol. 1994;267:E306-E315.
19. Blaak EE, van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. Beta-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects. Metabolism. 1995;44:183-187.
20. Blaak EE, Wagenmakers AJ, Glatz JF, Wolffenbuttel BH, Kemerink GJ, Langenberg CJ, Heidendal GA, Saris WH. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab. 2000;279:E146-E154.
21. Ferrario CM, Brosnihan KB, Chappell M. Measurements of angiotensin peptides. Hypertension. 1995;26:843-845.
22. Mikhail N, Golub MS, Tuck ML. Obesity and hypertension. Prog Cardiovasc Dis. 1999;42:39-58.
23. Zayas VM, Blumenfeld JD, Bading B, McDonald M, James GD, Lin YF, Sharrock NE, Sealey JE, Laragh JH. Adrenergic regulation of renin secretion and renal hemodynamics during deliberate hypotension in humans. Am J Physiol. 1993;265:F686-F692.
24. Sinaiko AR. Influence of adrenergic nervous and prostaglandin systems on hydralazine-induced renin release. Life Sci. 1983;33:2269-2275.
25. Pettinger WA, Mitchell HC. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man. N Engl J Med. 1975;292:1214-1217.
26. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548-2556.
27. Jones A, Woods DR. Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol. 2003;35:855-866.
28. Schling P, Schafer T. Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity. J Biol Chem. 2002;277:48066-48075.
29. Harte A, McTernan P, Chetty R, Coppack S, Katz J, Smith S, Kumar S. Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. Circulation. 2005;111:1954-1961.
30. Chai W, Danser AH. Is angiotensin II made inside or outside of the cell? Curr Hypertens Rep. 2005;7:124-127.
31. Salvetti A, Pedrinelli R, Magagna A, Poli L, Sassano P, Arzilli F. Influence of age and sodium intake on plasma renin activity of normal subjects. Nephron. 1980;26:189-194.
32. Giacchetti G, Faloia E, Sardu C, Camilloni MA, Mariniello B, Gatti C, Garrapa GG, Guerrieri M, Mantero F. Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord. 2000;24:S142-S143.
33. van Harmelen V, Elizalde M, Ariapart P, Bergstedt-Lindqvist S, Reynisdottir S, Hoffstedt J, Lundkvist I, Bringman S, Arner P. The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord. 2000;24:673-678.